TB Intensive Tyler, Texas December 2-4, 2008

Size: px
Start display at page:

Download "TB Intensive Tyler, Texas December 2-4, 2008"

Transcription

1 TB Intensive Tyler, Texas December 2-4, 2008 TB Case Presentations Douglas B. Hornick, MD December 3, 2008 Pulmonary Fascinomas with a Tuberculous Attitude Douglas B. Hornick, MD Professor University of Iowa College of Medicine Iowa City, Iowa 1

2 Ponder These Cases Proactive vs. Passive TB diagnosis University TB Speechless in Waterloo Gee whiz Granulomas Galore! Paradox Gee whiz too It s back Screening Early TB Detection 21 yo University student just arrived from India Screening program for new foreign students: + TST Asymptomatic, no exposure to active TB, +BCG hx, no HIV risk factors Chest x-ray (RUL small round cavitary infiltrate Made A Alim, referred by Fritzsche 2

3 More Data Unable to produce sputum in clinic, no AM sputum Bronchocopy: Transbronchial Bx negative, BAL AFB smears negative Two weeks elapses; Still asymptomatic; Balky What would you do now? Chest x-ray shows same RUL findings & evidence for new process LUL More Data Rx: INH, rifampin, pyrazinamide, & ethambutol, daily DOT (from date of abnormal chest x-ray) Four weeks: BAL cultures: Mycobacterium tuberculosis Six weeks: Susceptibilities show INH resistance Chest x-ray slightly improved What now? Add quinolone? Do you add 2 drugs? Do you stop INH & continue other meds? 3

4 Recall Basic Principles TB Rx Start Rx immediately upon suspicion for active TB Principles that underlie initiation of 4 drugs for active TB Use drugs to which the bugs are sensitive The more bugs, the more drugs Ensure adherence to Rx (DOT) Never add a single drug to a failing regimen INH Resistant TB Rx No reference studies Daily supervised Rx (not 2 or 3x/week) Consider extending Rx to 9 or 12 months Treatment options, stop INH and If pyrazinamide during 1 st 2 mos, continue rifampin & ethambutol x 9 mos. If PZA not used initially, use rifampin & ethambutol x12 mos If extensive disease: rifampin, pyrazinamide, & ethambutol plus quinolone (levo- or moxifloxacin) If responding, adding quinolone doesn t violate do not add single drug rule 4

5 INH Resistant TB Rx No reference studies Daily supervised Rx (not 2 or 3x/week) Consider extending Rx to 9 or 12 months Treatment options, stop INH and Rifampin, pyrazinamide, & ethambutol x 6 months If extensive disease: rifampin, pyrazinamide, & ethambutol plus quinolone (levo- or moxifloxacin) If responding, adding quinolone doesn t violate do not add single drug rule ATS, CDC, IDSA Guidelines 2003 Rest of the story Rifampin, ethambutol, pyrazinamide (daily DOT) continued x 9 months Chest x-ray complete resolution at end of Rx 5

6 Examples of Early TB Cases Detected Through Screening TST +, asymptomatic, CXR abnormal, sputum often AFB smear negative (culture positive) General: Less severe disease, easier to cure Seattle-King County: 11% of TB cases identified via screening Yield of screening varies (case detection/screened): Immigrants/refugees B1, B2 classification: 2-14% Homeless shelter (outbreak): 3.1, 4.3 % Contact investigations: 1-3% Inner City residents seeking SS: 0.5% Homeless Shelter (routine): 0.18, 0.36% Correctional facility intake: 0.07, 0.17% University intake foreign born students:???? CDC: MMWR Rec & Reports 54(RR12) 2005 Screening Early TB Detection +TST, BCG hx, Subtle CXR infilt., Smear-, Culture+ Comprehensive TB screening of foreign-born students Active cases occasionally surface: +TST, asymptomatic, BCG, Balky Subtle, non-cavitary chest x-ray infiltrate Smear negative, culture positive (AM sputum x3) Bronchoscopy in many but not all Note: Smear negative, culture negative uncommon Often faster response to treatment (small organism burden) Successful management: Teamwork Vigilant/Supportive Student Health Service University Administration ($ for testing, QFT-G) Department of Public Health Unique TB Presentation Proactive instead of Passive Process 6

7 R Upper Lobe Bronchus Intermedius Viet Nam Korea Philippines Screening Early TB Argentina Malaysia Smear-, Culture- India Case 41 yo WF, rural Iowa, NH aid, HIV-, no IVDA, no travel 1995 PPD+, CXR normal, INH x6 mos 1999, 2000 Chest X-ray: bilateral UL infiltrates First Episode 12/01 Hemoptysis, smear/culture positive, CXR bilateral UL infiltrates No contact conversions outside of immediate family (no NH contacts) Rx (?DOT) x 6 months: INH 300, Rif 600, PZA 500 daily x 4 weeks INH 750, Rif 600, PZA 3000 twice/week x4 weeks 12 weeks smear & cultures negative INH 750, Rif 600 twice/week x16 weeks Relapse 8/02 Smear/culture positive Pansusceptible TB, No new cases in contacts & NH CXR bilateral UL infiltrates 7

8 Received standard ATS/IDSA/CDC Rx DOT x9 months Smear & Culture - by 4mos Asymptomatic 6 months after Rx completion Sputum smear/culture negative It s Back 12/05 (~3 years later) Relapse 2 Pan susceptible TB; DNA fingerprinting: all isolates identical No new cases in contacts & NH CXR bilateral UL infiltrates, RUL more dense & cavitary Analogous case: 31 yo Bosnian male, relapse 2 Well documented DOT for prior 2 Rx courses From a county w/ experience & good track record for DOT Complete immunodeficiency w/u nothing useful DNA fingerprinting: all isolates identical Do you see this? What would you do in these cases? Both patients received daily DOT x 12 mos (+PZA) 8

9 (After r/o drug resistant TB) Suggestions Add PZA to regimen for increased intracellular therapeutic activity Check serum drug levels increased doses required Peloquin lab, National Jewish Check isolates against database strains which are prone to relapse (not d/t drug resistance, not necessarily related to virulence/contagion) Steve Holland lab, NIAID Patrick Moonan lab, CDC Case 41 yo WF, rural Iowa, NH aid, HIV-, no IVDA, no travel 1995 PPD+, CXR nor mal, INH x6 mos 1999, 2000 Chest X-ray: bi lateral UL infiltrates First Episode 12/01 Hemoptysis, smear/culture positive, CXR bilateral UL infiltrates No contact co nversions outside of immediate family (no NH contacts) Rx (?DOT) x 6 months: INH 300, Rif 600, PZA 500 daily x 4 weeks INH 750, Rif 600, PZA 3000 twice/week x4 weeks 12 weeks sme ar & cultures negative INH 750, Rif 600 twice/week x16 weeks Relapse 8/02 Smear/culture po sitive Pansusceptib le TB, No new DOT cases x9 in months contacts & NH Smear & Culture- by 4mos CXR bilateral UL infiltrates Sputum smear/culture negative Received standard ATS/IDSA/CDC Rx Asymptomatic 6 months after Rx completion 9

10 It s Back 12/05 (~3 years later) Relapse 2 Pan susceptible TB; DNA fingerprinting: all isolates identical No new cases in contacts & NH CXR bilateral UL infiltrates, RUL more dense & cavitary Analogous case: 31 yo Bosnian male, relapse 2 Well documented DOT for prior 2 Rx courses From a county w/ experience & good track record for DOT Complete immunodeficiency w/u nothing useful DNA fingerprinting: all isolates identical Do you see this? What would you do in these cases? Both patients received daily DOT x 12 mos (+PZA) (After r/o drug resistant TB) Suggestions Add PZA to regimen for increased intracellular therapeutic activity Check serum drug levels increased doses required Peloquin lab, National Jewish Check isolates against database strains which are prone to relapse (not d/t drug resistance, not necessarily related to virulence/contagion) Steve Holland lab, NIAID Patrick Moonan lab, CDC 10

11 JP: 4 mos Rx, 2 nd Relapse JP: 7 mos Rx, 2 nd Relapse OA: 9/05 Relapse 2 OA: DOT daily x 4 drugs 3/06 11

12 Unusual Extrapulm TB Case(s) 66 yo mildly mentally retarded male who lives alone Presented with rectal pain & biopsy showed inflammation c/w Crohns disease Rectal/GI symptoms worsened despite Prednisone Referred UIHC evaluation starting Inflixamab Chest x-ray abnormalities raised concerns Unable to produce sputum, TST negative Thoracentesis: yellow fluid, exudate, ph 7.25, WBC 14K (12K PMNs, 0.1K L) Gram stain: Many WBCs, no organisms; AFB negative What next? Pleural biopsy: No granulomas Acute Inflammation w/ many AFB Subsequent sputum AFB smear positive Rest of the story: Retrospective AFB stain of rectal biopsy: sheets of AFB (No Granulomas!) W/u for immune deficiency: HIV, INF & other immune deficiency negative Organisms pan susceptible DOT (daily) Treatment: 4 drugs x 2 months, then INH/Rif x 9 months Cured; no relapse or other infections (f/u 2 yrs after finishing Rx) 12

13 Gee Whiz Pleural/Pulmonary/Rectal TB Dangerous TB Case: Unsuspected plus steroid Rx AFB positive, no granulomas! (?immunodeficiency) Pleural TB Small number of organisms cause extensive reaction (hypersensitivity) Pleural fluid: lymphocyte predominant, low ph, AFB smear & culture positive ~20%, elevated adenosine deaminase Pleural biopsy w/ culture: positive ~75% (x2, to 90%) Check out the far end of the pleural infection spectrum 18-year-old man w/ no clinically significant medical history, six-month history of an increasing mass on the left side of his back (Panel A) 3 days before seen Serous drainage from L chest CT: Pleural nodules, empyema fluid encasing L lung & leaking out Pleural fluid & bx negative AFB, but granulomas & culture positive Empyema Necessitatis Chaiyasate, K. et al. N Engl J Med 2005;352:e8 13

14 TB Laryngitis Case 31 yo Bosnian female w/ hoarseness, neck swelling, pain & dyspnea worsening over 5 months. ENT: ulcerated lesions on epiglottis & VC Biopsy: granulomas, but no AFB, culture negative Neck LN needle: lymphocytes, no AFB, not cultured Neck CT: bilateral adenopathy Radiologist noted infiltrates could be seen in few cuts that showed upper lung fields! Past Hx: TST positive 1 yr previous, CXR showed upper lobe infiltrates, sputum smears x3 negative, Rx stopped after ~14days (pt refused/disappeared) 14

15 Any cavitation? How would you treat? Culture showed pan-susceptible TB Isoniazid, Rifampin, Pyrazinamide, & Ethambutol (all x 2 months, then INH/Rif) twice weekly DOT. 15

16 Outcome Public Health: Although sputum 3+ smear positive, Oto MD/staff already TST+ didn t become re-infected. Patient: Hoarseness, neck pain/swelling & dyspnea resolved quickl y on Rx Standard DOT x9 months (no relapse >2 y rs f/u) Midpoint 6 mos post Rx Speechless in Waterloo Laryngeal TB Symptoms by frequency: hoarseness, dys-, odynophagia Presentation varies w/ TB epidemiology: High rate untreated TB: Manifestation a/w extensive cavitary TB in lung Ulcerative lesions VC, posterior larynx d/t supine & pooling infectious secretions Effective Rx & HIV era still common a/w cavitary lung ds but Can be initial TB manifestation d/t lymphohematogenous spread: HIV: Sentinel opportunistic infection Non-HIV: Reactivation Anterior laryngeal lesions (hypertrophic & ulcerative less often) Biopsy recommended: TB lesions mimic Squamous Cell Ca biopsy those w/ RF for laryngeal Ca overlap w/ typical TB population. TB Rx results in resolution within weeks VC fibrosis & permanent hoarseness rare complication 16

17 Disseminated TB Case 32 yo female Grad student (Chemistry) from India w/ cough, DOE, & fever x2 wks 8 months previous: Arrived in US, TST negative x2 (1 st 6 mos in Texas, roommate Rx for TB), HIV neg, CXR normal CXR abnormal Pleural fluid: bloody, exudate, ph 7.44, Gm stain: many WBC, No organisms; AFB negative Dx: CAP w/ uncomplicated parapneumonic effusion All bacterial cultures negative, sputum AFB neg, TST neg, HIV neg D/C home (azithromycin/cefpodoxime) after 4 days in hospital Note: fever on da y of discharge (Na 130) 17

18 She s Back 2 weeks post d/c, friends bring SJ to ER: couple days of weird behavior, then confused, aphasic Na 128 Head CT: L frontal lobe hemorrhage & edema; at least 5 <1 cm ring enhancing lesions Brain MRI: L frontal lobe edema; many <1 cm ring enhancing lesions (at least 11 in both lobes of cerebellum!) 18

19 Now What? DDx: Bacterial cerebritis, Toxoplasmosis, disseminated Histo or TB Rx: ceftriaxone, flagyl, pyrimethamine, amphotericin B, Isoniazid, Rifampin, Pyrazinamide, & Ethambutol!! Work-up continues: Unable to produce sputum for AFB smears Chest CT: nonspecific diffuse, bilateral nodular infiltrate, pleural Massive Grand Mal seizure ICU, respiratory failure, mechanical ventilation effusion improved Bone marrow: multiple granulomas, fungus/afb stains neg Liver biopsy: necrotizing granulomas, fungus/afb stains neg Trach aspirate: fungus/afb stains negative VATS lung & pleural biopsy: necrotizing granulomas, fungus/afb stains negative Stool & small bowel aspirate: fungus/afb stains negative Repeat trach aspirates x3: on one, a single AFB seen! 3 weeks later: Liver, pleural, lung biopsies, & trach aspirates all grow pan-susceptible M. tuberculosis Granulomas Galore! Outcome: DOT x9 mos (no recurrence), L frontal encephalomalacia, residual seizures (less frequent w/ time), minimal R hemiplegia & cognitive defects (improved w/ time) Disseminated TB (non HIV) CNS TB (non HIV) Very young children; patients >60 Primary or reactivation; granulomas in multiple organs TST negative 25-40% Sputum for AFB negative in most cases Lung radiographs: multiple sm. nodules (1-2 mm) miliary For diagnosis: Biopsy organ most involved (symptoms) & send culture Rx: no different than pulmonary TB Notoriously difficult diagnosis Many have no lung disease, nonspecific symptoms (HA, low grade fever) initially, then progress to confusion, CN palsy, hemiplegia CSF: high protein, lymphocytosis, AFB smear & culture low yield (PCR disappointing tuberculostearic acid by GLC very sensitive, where available) Steroids recommended (CN palsy, cerebral edema, CSF protein) High index of suspicion for TB required! 19

TB Intensive San Antonio, Texas December 1-3, 2010

TB Intensive San Antonio, Texas December 1-3, 2010 TB Intensive San Antonio, Texas December 1-3, 2010 TB Case Presentations Doug Hornick, MD; Iowa U Medical School December 1, 2010 Pulmonary Fascinomas with a Tuberculous Attitude Douglas B. Hornick, MD

More information

Pulmonary Fascinomas with a Tuberculosis Attitude. Douglas Hornick, MD Medical Consultant Meeting November 29-30th, 2018.

Pulmonary Fascinomas with a Tuberculosis Attitude. Douglas Hornick, MD Medical Consultant Meeting November 29-30th, 2018. Pulmonary Fascinomas with a Tuberculosis Attitude Douglas Hornick, MD Medical Consultant Meeting November 29-30th, 2018 EXCELLENCE EXPERTISE INNOVATION 1 Disclosures Douglas Hornick, MD has the following

More information

Diagnosis and Medical Management of Latent TB Infection

Diagnosis and Medical Management of Latent TB Infection Diagnosis and Medical Management of Latent TB Infection Marsha Majors, RN September 7, 2017 TB Contact Investigation 101 September 6 7, 2017 Little Rock, AR EXCELLENCE EXPERTISE INNOVATION Marsha Majors,

More information

Pediatric Tuberculosis Lisa Y. Armitige, MD, PhD September 14, 2017

Pediatric Tuberculosis Lisa Y. Armitige, MD, PhD September 14, 2017 Pediatric Tuberculosis Lisa Y. Armitige, MD, PhD September 14, 2017 TB Nurse Case Management September 12 14, 2017 EXCELLENCE EXPERTISE INNOVATION Lisa Y. Armitige, MD, PhD has the following disclosures

More information

Treatment of Tuberculosis, 2017

Treatment of Tuberculosis, 2017 Treatment of Tuberculosis, 2017 Charles L. Daley, MD National Jewish Health University of Colorado Health Sciences Center Treatment of Tuberculosis Disclosures Advisory Board Horizon, Johnson and Johnson,

More information

Tuberculosis Tools: A Clinical Update

Tuberculosis Tools: A Clinical Update Tuberculosis Tools: A Clinical Update CAPA Conference 2014 JoAnn Deasy, PA-C. MPH, DFAAPA jadeasy@sbcglobal.net Adjunct Faculty Touro PA Program Learning Objectives Outline the pathogenesis of active pulmonary

More information

TB Nurse Case Management San Antonio, Texas April 9-11, 2013

TB Nurse Case Management San Antonio, Texas April 9-11, 2013 TB Nurse Case Management San Antonio, Texas April 9-11, 2013 TB / Dose Counting Rachel Munoz, RN. TB Nurse Case Manager/Nurse Consultant Austin/Travis County Health Department April 10, 2013 Rachel Munoz,

More information

Errors in Dx and Rx of TB

Errors in Dx and Rx of TB Errors in Dx and Rx of TB David Schlossberg, MD, FACP Professor of Medicine Temple University School of Medicine Medical Director, TB Control Program Philadelphia Department of Public Health TB Still a

More information

Diagnosis and Treatment of Tuberculosis, 2011

Diagnosis and Treatment of Tuberculosis, 2011 Diagnosis of TB Diagnosis and Treatment of Tuberculosis, 2011 Alfred Lardizabal, MD NJMS Global Tuberculosis Institute Diagnosis of TB, 2011 Diagnosis follows Suspicion When should we Think TB? Who is

More information

TB Intensive Houston, Texas. Childhood Tuberculosis Kim Connelly Smith. November 12, 2009

TB Intensive Houston, Texas. Childhood Tuberculosis Kim Connelly Smith. November 12, 2009 TB Intensive Houston, Texas November 10-12, 12 2009 Childhood Tuberculosis Kim Connelly Smith MD, MPH November 12, 2009 Childhood Tuberculosis Kim Connelly Smith MD, MPH November 12, 2009 1 OUTLINE Stages

More information

TB: Management in an era of multiple drug resistance. Bob Belknap M.D. Denver Public Health November 2012

TB: Management in an era of multiple drug resistance. Bob Belknap M.D. Denver Public Health November 2012 TB: Management in an era of multiple drug resistance Bob Belknap M.D. Denver Public Health November 2012 Objectives: 1. Explain the steps for diagnosing latent and active TB role of interferon-gamma release

More information

Diagnosis & Medical Case Management of TB Disease. Lisa Armitige, MD, PhD October 22, 2015

Diagnosis & Medical Case Management of TB Disease. Lisa Armitige, MD, PhD October 22, 2015 Diagnosis & Medical Case Management of TB Disease Lisa Armitige, MD, PhD October 22, 2015 Comprehensive Care of Patients with Tuberculosis and Their Contacts October 19 22, 2015 Wichita, KS EXCELLENCE

More information

TB In Detroit 2011* Early TB: Smudge Sign. Who is at risk for exposure to or infection with TB? Who is at risk for TB after exposure or infection?

TB In Detroit 2011* Early TB: Smudge Sign. Who is at risk for exposure to or infection with TB? Who is at risk for TB after exposure or infection? Those oral antibiotics are just not working! Inpatient Standards of Care & Discharge Planning S/He s in the Hospital: Now What Do I Do? Dana G. Kissner, MD TB Intensive Workshop, Lansing, MI 2012 Objectives:

More information

has the following disclosures to make:

has the following disclosures to make: CLINICAL DIAGNOSIS AND MANAGEMENT OF TB DISEASE Annie Kizilbash MD, MPH September 22, 2015 TB Nurse Case Management September 22 24, 2015 San Antonio. TX EXCELLENCE EXPERTISE INNOVATION Annie Kizilbash

More information

Pediatric TB Lisa Armitige, MD, PhD September 28, 2011

Pediatric TB Lisa Armitige, MD, PhD September 28, 2011 TB Nurse Case Management Davenport, Iowa September 27 28, 2011 Pediatric TB Lisa Armitige, MD, PhD September 28, 2011 Lisa Armitige, MD, PhD has the following disclosures to make: No conflict of interest.

More information

DIAGNOSIS AND MEDICAL MANAGEMENT OF TB DISEASE

DIAGNOSIS AND MEDICAL MANAGEMENT OF TB DISEASE DIAGNOSIS AND MEDICAL MANAGEMENT OF TB DISEASE Annie Kizilbash MD, MPH Assistant Professor University of Texas Health Science Center Staff Physician, Texas Center for Infectious Diseases TB Nurse Case

More information

TB Classification (ATS/CDC)

TB Classification (ATS/CDC) bits and pieces Lisa Chen, MD UCSF Pulmonary/Critical Care Curry International Tuberculosis Center 10/2017 TB Classification (ATS/CDC) TB0 No tuberculosis exposure, not infected TB1 Tuberculosis exposure,

More information

TB Nurse Case Management San Antonio, Texas March 7 9, Pediatric TB Kim Connelly Smith, MD, MPH March 8, 2012

TB Nurse Case Management San Antonio, Texas March 7 9, Pediatric TB Kim Connelly Smith, MD, MPH March 8, 2012 TB Nurse Case Management San Antonio, Texas March 7 9, 2012 Pediatric TB Kim Connelly Smith, MD, MPH March 8, 2012 Kim Connelly Smith, MD, MPH has the following disclosures to make: No conflict of interests

More information

TB Nurse Case Management San Antonio, Texas July 18 20, 2012

TB Nurse Case Management San Antonio, Texas July 18 20, 2012 TB Nurse Case Management San Antonio, Texas July 18 20, 2012 Pediatric TB Kim Smith, MD, MPH July 19, 2012 Kim Smith, MD, MPH has the following disclosures to make: No conflict of interests No relevant

More information

Recognizing MDR-TB in Children. Ma. Cecilia G. Ama, MD 23 rd PIDSP Annual Convention February 2016

Recognizing MDR-TB in Children. Ma. Cecilia G. Ama, MD 23 rd PIDSP Annual Convention February 2016 Recognizing MDR-TB in Children Ma. Cecilia G. Ama, MD 23 rd PIDSP Annual Convention 17-18 February 2016 Objectives Review the definitions and categorization of drugresistant tuberculosis Understand the

More information

Managing Complex TB Cases Diana M. Nilsen, MD, RN

Managing Complex TB Cases Diana M. Nilsen, MD, RN Managing Complex TB Cases Diana M. Nilsen, MD, RN Director of Medical Affairs NYC Department of Health & Mental Hygiene Bureau of TB Control Case #1 You are managing a patient who was seen at a private

More information

10/3/2017. Updates in Tuberculosis. Global Tuberculosis, WHO 2015 report. Objectives. Disclosures. I have nothing to disclose

10/3/2017. Updates in Tuberculosis. Global Tuberculosis, WHO 2015 report. Objectives. Disclosures. I have nothing to disclose Disclosures Updates in Tuberculosis I have nothing to disclose Chris Keh, MD Assistant Clinical Professor, Division of Infectious Diseases, UCSF TB Controller, TB Prevention and Control Program, Population

More information

What the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Global Impact of TB

What the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Global Impact of TB What the Primary Physician Should Know about Tuberculosis Henry F. Chambers, M.D Professor of Medicine, UCSF Topics for Discussion Epidemiology Common disease presentations Diagnosis of active TB Screening

More information

Chapter 22. Pulmonary Infections

Chapter 22. Pulmonary Infections Chapter 22 Pulmonary Infections Objectives State the incidence of pneumonia in the United States and its economic impact. Discuss the current classification scheme for pneumonia and be able to define hospital-acquired

More information

An Introduction to Radiology for TB Nurses

An Introduction to Radiology for TB Nurses An Introduction to Radiology for TB Nurses Garold O. Minns, MD September 14, 2017 TB Nurse Case Management September 12 14, 2017 EXCELLENCE EXPERTISE INNOVATION Garold O. Minns, MD has the following disclosures

More information

Patient History 1. Patient History 2. Social History. The Role of Surgery in the Management of TB. Reynard McDonald, MD & Paul Bolanowski, MD

Patient History 1. Patient History 2. Social History. The Role of Surgery in the Management of TB. Reynard McDonald, MD & Paul Bolanowski, MD Patient History 1 The Role of Surgery in the Management of TB Reynard McDonald, MD & Paul Bolanowski, MD September 16, 2010 42 y/o AA male was initially diagnosed with pansensitive pulmonary TB in 1986

More information

Treatment of Tuberculosis

Treatment of Tuberculosis TB Clinical i l Intensive Seattle Treatment of Tuberculosis June 16, 2016 Masa Narita, MD Public Health Seattle & King County; Firland Northwest TB Center, University of Washington Outline Unique features

More information

INDEX CASE INFORMATION

INDEX CASE INFORMATION Instructions for Completing the MDH Tuberculosis Contact Investigation Report Form Please provide as much information as possible. Each field represents information that is important to the contact investigation.

More information

What the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Life Cycle of M. tuberculosis

What the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Life Cycle of M. tuberculosis What the Primary Physician Should Know about Tuberculosis Henry F. Chambers, M.D Professor of Medicine, UCSF Topics for Discussion Microbiology Epidemiology Common disease presentations Diagnosis of active

More information

Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis

Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis Henry F. Chambers, M.D Professor of Medicine, UCSF Topics for Discussion Epidemiology Diagnosis of active TB Screening

More information

Scott Lindquist MD MPH Tuberculosis Medical Consultant Washington State DOH and Kitsap County Health Officer

Scott Lindquist MD MPH Tuberculosis Medical Consultant Washington State DOH and Kitsap County Health Officer Tuberculosis in the 21 st Century Scott Lindquist MD MPH Tuberculosis Medical Consultant Washington State DOH and Kitsap County Health Officer Feedback Poll In my opinion, the recent media coverage of

More information

Diagnosis and Medical Management of TB Disease. Quratulian Annie Kizilbash, MD, MPH March 17, 2015

Diagnosis and Medical Management of TB Disease. Quratulian Annie Kizilbash, MD, MPH March 17, 2015 Diagnosis and Medical Management of TB Disease Quratulian Annie Kizilbash, MD, MPH March 17, 2015 TB Nurse Case Management March 17 19, 2015 San Antonio, Texas EXCELLENCE EXPERTISE INNOVATION Quratulian

More information

TB Radiology for Nurses Garold O. Minns, MD

TB Radiology for Nurses Garold O. Minns, MD TB Nurse Case Management Salina, Kansas March 31-April 1, 2010 TB Radiology for Nurses Garold O. Minns, MD April 1, 2010 TB Radiology for Nurses Highway Patrol Training Center Salina, KS April 1, 2010

More information

Tuberculosis Intensive

Tuberculosis Intensive Tuberculosis Intensive San Antonio, Texas April 3 6, 2012 Childhood Tuberculosis Kim Smith, MD, MPH April 6, 2012 Kim Smith, MD, MPH has the following disclosures to make: No conflict of interests No relevant

More information

TB in the Correctional Setting Florence, Arizona October 7, 2014

TB in the Correctional Setting Florence, Arizona October 7, 2014 TB in the Correctional Setting Florence, Arizona October 7, 2014 Diagnosis and Treatment of TB Disease Renuka Khurana, MBBS, MPH October 7, 2014 Renuka Khurana, MSSB, MPH has the following disclosures

More information

Tuberculosis Intensive November 17 20, 2015 San Antonio, TX

Tuberculosis Intensive November 17 20, 2015 San Antonio, TX Treatment of Tuberculosis Elizabeth S. Guy, MD November 17, 2015 Tuberculosis Intensive November 17 20, 2015 San Antonio, TX EXCELLENCE EXPERTISE INNOVATION Elizabeth S. Guy, MD has the following disclosures

More information

Tuberculosis in Primary Care COC GTA Spring Symposium Dr Elizabeth Rea April 2013

Tuberculosis in Primary Care COC GTA Spring Symposium Dr Elizabeth Rea April 2013 Tuberculosis in Primary Care COC GTA Spring Symposium Dr Elizabeth Rea April 2013 1 TB in Toronto - risk groups Diagnosis of active TB LTBI diagnosis and management Infection control 2 TB in Toronto Case

More information

CLINICAL DIAGNOSIS AND MANAGEMENT OF TB Disease

CLINICAL DIAGNOSIS AND MANAGEMENT OF TB Disease CLINICAL DIAGNOSIS AND MANAGEMENT OF TB Disease Barbara J Seaworth MD Medical Director Heartland National TB Center Professor of Medicine University of Texas Health Center Tyler Barbara J Seaworth MD has

More information

When Can Isolation Be Discontinued?

When Can Isolation Be Discontinued? When Can Isolation Be Discontinued? - It Depends on the Patient and the Setting. Masae Kawamura M.D. and Barbara Seaworth M.D. Texas: (800) TEX-LUNG New Jersey: 973-972-3270? HNTC Consultation Line California:

More information

CHAPTER:1 TUBERCULOSIS. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY

CHAPTER:1 TUBERCULOSIS. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY CHAPTER:1 TUBERCULOSIS BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY GLOBAL EMERGENCY: * Tuberculosis kills 5,000 people a day! * 2.3 million die each year!

More information

My heart is racing. Managing Complex Cases. Case 1. Case 1

My heart is racing. Managing Complex Cases. Case 1. Case 1 Managing Complex Cases My heart is racing Amee Patrawalla, MD April 7, 2017 Case 1 Rutgers, The State University of New Jersey Rutgers, The State University of New Jersey Case 1 29 year old physician from

More information

TB Intensive Houston, Texas

TB Intensive Houston, Texas TB Intensive Houston, Texas October 15-17, 17 2013 Diagnosis of TB: Radiology Rosa M Estrada-Y-Martin, MD MSc FCCP October 16, 2013 Rosa M Estrada-Y-Martin, MD MSc FCCP, has the following disclosures to

More information

At the end of this session, participants will be able to:

At the end of this session, participants will be able to: Advanced Concepts in Pediatric Tuberculosis: Infection Control, Source Case and Contact Investigation Ana M. Alvarez, M.D. Associate Professor Division of Pediatric Infectious Diseases and Immunology University

More information

New Tuberculosis Guidelines. Jason Stout, MD, MHS

New Tuberculosis Guidelines. Jason Stout, MD, MHS New Tuberculosis Guidelines Jason Stout, MD, MHS Two New Sets of Guidelines Treatment of Drug-Susceptible Tuberculosis Clinical Infectious Diseases 2016; 63(7): e147-e195 Diagnosis of Tuberculosis in Adults

More information

Fundamentals of Tuberculosis (TB)

Fundamentals of Tuberculosis (TB) TB in the United States Fundamentals of Tuberculosis (TB) From 1953 to 1984, reported cases decreased by approximately 5.6% each year From 1985 to 1992, reported cases increased by 20% 25,313 cases reported

More information

Research in Tuberculosis: Translation into Practice

Research in Tuberculosis: Translation into Practice Case History Research in Tuberculosis: Translation into Practice This is a 6-year6 year-old Bosnian male, who presented to ER with one-week history of fever and occasional vomiting. No cough, difficulty

More information

TB and Comorbidities Adriana Vasquez, MD April 12, 2018

TB and Comorbidities Adriana Vasquez, MD April 12, 2018 TB and Comorbidities Adriana Vasquez, MD April 12, 2018 TB Nurse Case Management April 10 12, 2018 San Antonio, TX EXCELLENCE EXPERTISE INNOVATION Adriana Vasquez, MD has the following disclosures to make:

More information

3/25/2012. numerous micro-organismsorganisms

3/25/2012. numerous micro-organismsorganisms Congenital & Neonatal TB A Case of Tuberculosis Congenital or Acquired? Felicia Dworkin, MD NYC DOHMH Bureau TB Control World TB Day March 23, 2012 Congenital TB: acquired by the fetus during pregnancy

More information

Moving Past the Basics of Tuberculosis Phoenix, Arizona May 8-10, 2012

Moving Past the Basics of Tuberculosis Phoenix, Arizona May 8-10, 2012 Moving Past the Basics of Tuberculosis Phoenix, Arizona May 8-10, 2012 LTBI and TB Disease Treatment Cara Christ, MD, MS May 8, 2012 Cara Christ, MD, MS has the following disclosures to make: No conflict

More information

TB in Foreign Born and High Risk Populations

TB in Foreign Born and High Risk Populations TB Nurse Case Management San Antonio, Texas December 8-10, 2009 TB in Foreign Born and High Risk Populations John J. Nava, M.D. December 9, 2009 Tuberculosis in High Risk Populations and the Foreign Born

More information

Tuberculosis Populations at Risk

Tuberculosis Populations at Risk Tuberculosis Populations at Risk One-third of the world is infected with TB, an average of one new infection per second Two million people died from tuberculosis in 2010, 1 every 20 seconds TB is the leading

More information

Tuberculosis and Diabetes Mellitus. Lana Kay Tyer, RN MSN WA State Department of Health TB Nurse Consultant

Tuberculosis and Diabetes Mellitus. Lana Kay Tyer, RN MSN WA State Department of Health TB Nurse Consultant Tuberculosis and Diabetes Mellitus Lana Kay Tyer, RN MSN WA State Department of Health TB Nurse Consultant Learning Objectives Understand the impact of uncontrolled diabetes mellitus (DM) on TB infection

More information

Diagnosis and Management of TB Disease Lisa Armitige, MD, PhD September 27, 2011

Diagnosis and Management of TB Disease Lisa Armitige, MD, PhD September 27, 2011 TB Nurse Case Management Davenport, Iowa September 27 28, 2011 Diagnosis and Management of TB Disease Lisa Armitige, MD, PhD September 27, 2011 Lisa Armitige, MD, PhD has the following disclosures to make:

More information

Analysis. Answers. Action. Saturday Night Fever. Shaka Brown Capital Congress

Analysis. Answers. Action.   Saturday Night Fever. Shaka Brown Capital Congress Saturday Night Fever Shaka Brown Capital Congress Shaka Zulu October 31, 2012 SICK SUCKS How my illness started October 2013 August to October 2013 Symptoms: Severe fatigue Night sweats Low grade fever

More information

Pre-Treatment Evaluation. Treatment of Latent TB Infection (LTBI) Initiating Treatment: Patient Education. Before initiating treatment for LTBI:

Pre-Treatment Evaluation. Treatment of Latent TB Infection (LTBI) Initiating Treatment: Patient Education. Before initiating treatment for LTBI: Pre-Treatment Evaluation Before initiating treatment for LTBI: Treatment of Latent TB Infection (LTBI) Amee Patrawalla, MD Associate Professor, New Jersey Medical School Attending Physician, NJMS Global

More information

Tuberculosis: update 2013

Tuberculosis: update 2013 Tuberculosis: update 2013 William R. Bishai, MD, PhD Center for TB Research Division of Infectious Diseases Department of Medicine Johns Hopkins School of Medicine Question 1 A TB speaker at a major conference

More information

TUBERCULOSIS. Presented By: Public Health Madison & Dane County

TUBERCULOSIS. Presented By: Public Health Madison & Dane County TUBERCULOSIS Presented By: Public Health Madison & Dane County What is Tuberculosis? Tuberculosis, or TB, is a disease caused by a bacteria called Mycobacterium tuberculosis. The bacteria can attack any

More information

Advanced Management of Patients with Tuberculosis Little Rock, Arkansas August 13 14, 2014

Advanced Management of Patients with Tuberculosis Little Rock, Arkansas August 13 14, 2014 Advanced Management of Patients with Tuberculosis Little Rock, Arkansas August 13 14, 2014 TB Case Presentation Andrea Cruz, MD, MPH August 14, 2014 Andrea Cruz, MD, MPH has the following disclosures to

More information

Treatment of Tuberculosis

Treatment of Tuberculosis TB Intensive Tyler, Texas June 1-3, 2009 Treatment of Tuberculosis Barbara Seaworth, MD June 3, 2009 Treatment of Tuberculosis Barbara J Seaworth MD Medical Director Heartland National TB Center 1 Purpose

More information

TB Intensive San Antonio, Texas August 7-10, 2012

TB Intensive San Antonio, Texas August 7-10, 2012 TB Intensive San Antonio, Texas August 7-10, 2012 An Introduction to Childhood Tuberculosis Kim Smith, MD, MPH August 10, 2012 Kim Smith, MD, MPH has the following disclosures to make: No conflict of interests

More information

Tuberculosis in the Traveler

Tuberculosis in the Traveler Tuberculosis in the Traveler Waterloo-Wellington Cardiovascular Respiratory Conference April 27 th, 2016 The Beat on Breathing Watch, Treat or Admit? disclosures No Potential for conflict of interest Staffed

More information

TB in the Patient with HIV

TB in the Patient with HIV TB in the Patient with HIV Lisa Y. Armitige, MD, PhD May 11, 2017 TB Intensive May 9 12, 2017 San Antonio, TX EXCELLENCE EXPERTISE INNOVATION Lisa Y. Armitige, MD, PhD, has the following disclosures to

More information

I. Demographic Information GENDER NUMBER OF CASES PERCENT OF CASES. Male % Female %

I. Demographic Information GENDER NUMBER OF CASES PERCENT OF CASES. Male % Female % San Joaquin County (SJC) in 03, (N=43) County Rate = 6. Cases per 00,000 Population I. Demographic Information Table I-A: TB cases by gender, SJC, 03 (N=43) GENDER NUMBER OF CASES Male 6 60.5% Female 7

More information

TB, or NOT TB? A Tough Question in Kids!

TB, or NOT TB? A Tough Question in Kids! TB, or NOT TB? A Tough Question in Kids! Brian Lee, MD Pediatric Tuberculosis Program Division of Infectious Diseases Ken Martin, MD Division of Radiology Overview Illustrate the range of clinical scenarios

More information

Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016

Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016 Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016 Randy Culpepper, MD, MPH Deputy Heath Officer/Medical Director Frederick County Health Department March 16, 2016 2 No

More information

The Diagnosis of Active TB. Deborah McMahan, MD TB Intensive September 28, 2017

The Diagnosis of Active TB. Deborah McMahan, MD TB Intensive September 28, 2017 The Diagnosis of Active TB Deborah McMahan, MD TB Intensive September 28, 2017 Agenda Epidemiology Big picture Conditions that Should Make You Suspicious Which test? Eeenie meenie miny mo Radiographic

More information

Managing the Patients Response to TB Treatment

Managing the Patients Response to TB Treatment Managing the Patients Response to TB Treatment Barbarah Martinez, RN, BSN September 13, 2017 TB Nurse Case Management September 12 14, 2017 EXCELLENCE EXPERTISE INNOVATION Barbarah Martinez, RN, BSN has

More information

Characteristics of Mycobacterium

Characteristics of Mycobacterium Mycobacterium Characteristics of Mycobacterium Very thin, rod shape. Culture: Aerobic, need high levels of oxygen to grow. Very slow in grow compared to other bacteria (colonies may be visible in up to

More information

Latent TB, TB and the Role of the Health Department

Latent TB, TB and the Role of the Health Department Latent TB, TB and the Role of the Health Department Elaine Darnall, RN, BSN, CIC TB Nurse Consultant Illinois Dept of Public Health March 21, 2018 Elaine Darnall has disclosed that there is no actual or

More information

Tuberculosis and Diabetes Dec. 10, 2009 Dean Schillinger, M.D. and Gisela Schecter, M.D., M.P.H. 1 of 18

Tuberculosis and Diabetes Dec. 10, 2009 Dean Schillinger, M.D. and Gisela Schecter, M.D., M.P.H. 1 of 18 Screening, Diagnosis, and Treatment of TB in Persons with Diabetes Dean Schillinger, M.D. University of California San Francisco CA Diabetes Program Gisela Schecter, M.D., M.P.H. TB Control Branch CA Department

More information

PULMONARY MEDICINE BOARD REVIEW. Financial Conflicts of Interest. Question #1: Question #1 (Cont.): None. Christopher H. Fanta, M.D.

PULMONARY MEDICINE BOARD REVIEW. Financial Conflicts of Interest. Question #1: Question #1 (Cont.): None. Christopher H. Fanta, M.D. PULMONARY MEDICINE BOARD REVIEW Christopher H. Fanta, M.D. Pulmonary and Critical Care Division Brigham and Women s Hospital Partners Asthma Center Harvard Medical School Financial Conflicts of Interest

More information

What you need to know about diagnosing and treating TB: a preventable, fatal disease. Bob Belknap M.D. Denver Public Health November 2013

What you need to know about diagnosing and treating TB: a preventable, fatal disease. Bob Belknap M.D. Denver Public Health November 2013 What you need to know about diagnosing and treating TB: a preventable, fatal disease Bob Belknap M.D. Denver Public Health November 2013 Case 1: 52 y/o male Born in the Pacific Islands; some travel in

More information

Pediatric TB Intensive Houston, Texas October 14, 2013

Pediatric TB Intensive Houston, Texas October 14, 2013 Pediatric TB Intensive Houston, Texas October 14, 2013 Diagnosis and Management of Tuberculosis in Adolescents Andrea T. Cruz, MD, MPH Sections of Infectious Diseases & Emergency Medicine October 14, 2013

More information

TB Grand Rounds. Reynard McDonald, MD & Henry Fraimow, MD January 30, Outline

TB Grand Rounds. Reynard McDonald, MD & Henry Fraimow, MD January 30, Outline TB Grand Rounds Reynard McDonald, MD & Henry Fraimow, MD January 30, 2007 Outline Overview of 2006 ATS statement regarding hepatotoxicity of anti-tb therapy Case examples highlighting management of patients

More information

Chapter 5 Treatment for Latent Tuberculosis Infection

Chapter 5 Treatment for Latent Tuberculosis Infection Chapter 5 Treatment for Latent Tuberculosis Infection Table of Contents Chapter Objectives.... 109 Introduction.... 111 Candidates for the Treatment of LTBI... 112 LTBI Treatment Regimens.... 118 LTBI

More information

Dr Francis Ogaro MTRH ELDORET

Dr Francis Ogaro MTRH ELDORET Dr Francis Ogaro MTRH ELDORET TB in children often severe, disseminated and can progress rapidly and with poor outcome TB diagnosis in children has relied on clinical, imaging, microscopy and TST findings.

More information

Annual Tuberculosis Report Oregon 2007

Annual Tuberculosis Report Oregon 2007 Annual Tuberculosis Report Oregon 7 Oregon Department of Human Services Public Health Division TB Program April 8 Page 2 Table of Contents Charts Chart 1 TB Incidence in the US and Oregon, 1985-7.. page

More information

Case Presentations Part 2

Case Presentations Part 2 Case Presentations Part 2 Connie A. Haley, MD MPH University of Florida, Infectious Diseases and Global Medicine Megan Ninneman, PA Jackson Memorial Hospital, Miami FL Objectives Demonstrate the ability

More information

Tuberculosis: A Provider s Guide to

Tuberculosis: A Provider s Guide to Tuberculosis: A Provider s Guide to Diagnosis and Treatment of Active Tuberculosis (TB) Disease and Screening and Treatment of Latent Tuberculosis Infection (LTBI) Alameda County Health Care Services Agency

More information

TUBERCULOSIS. Pathogenesis and Transmission

TUBERCULOSIS. Pathogenesis and Transmission TUBERCULOSIS Pathogenesis and Transmission TUBERCULOSIS Pathogenesis and Transmission Infection to Disease Diagnostic & Isolation Updates Treatment Updates Pathogenesis Droplet nuclei of 5µm or less are

More information

HEALTH SERVICES POLICY & PROCEDURE MANUAL

HEALTH SERVICES POLICY & PROCEDURE MANUAL PAGE 1 of 7 References Related ACA Standards 4 th Edition Standards for Adult Correctional Institutions 4-4350, 4-4355 These guidelines are based on the recommendations of the American Thoracic Society

More information

Radiological Aspects of Pulmonary Tuberculosis in Immunocompetent Hosts

Radiological Aspects of Pulmonary Tuberculosis in Immunocompetent Hosts Nov 2003 Radiological Aspects of Pulmonary Tuberculosis in Immunocompetent Hosts Josh Rempell, Harvard Medical School Year III Tuberculosis: the captain of all (wo)men of death Overall, one third of the

More information

Tuberculosis 6/7/2018. Objectives. What is Tuberculosis?

Tuberculosis 6/7/2018. Objectives. What is Tuberculosis? Tuberculosis Understanding, Investigating, Eliminating Jeff Maupin, RN Tuberculosis Control Nurse Sedgwick County Division of Health Objectives At the conclusion of this presentation, you will be able

More information

Disclosures. Updates in TB for the PCP: Opportunities for Prevention. Objectives PART 1: WHY TEST? 4/14/2016. None

Disclosures. Updates in TB for the PCP: Opportunities for Prevention. Objectives PART 1: WHY TEST? 4/14/2016. None Disclosures Updates in TB for the PCP: Opportunities for Prevention None Pennan Barry, MD, MPH Chief, Surveillance and Epidemiology, California TB Control Branch Assistant Clinical Professor, Division

More information

Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection (LTBI) Lloyd Friedman, M.D. Milford Hospital Yale University

Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection (LTBI) Lloyd Friedman, M.D. Milford Hospital Yale University Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection (LTBI) Lloyd Friedman, M.D. Milford Hospital Yale University Tuberculosis Estimates USA World Infection 15,000,000 2,000,000,000

More information

Utilizing All the Tools in the TB Toolbox

Utilizing All the Tools in the TB Toolbox Utilizing All the Tools in the TB Toolbox Sandra Morano, B.A., R.N. Public Health Nurse, City of Stamford, CT TB Talk The New England TB Consortium March 18, 2010 Background TB Program, City of Stamford,

More information

TB Update: March 2012

TB Update: March 2012 TB Update: March 2012 David Schlossberg, MD, FACP Medical Director, TB Control Program Philadelphia Department of Public Health 1 TB Update: March 2012 IGRAs vs TST LTBI A New Regimen NAATs What is Their

More information

TB Intensive San Antonio, Texas November 11 14, 2014

TB Intensive San Antonio, Texas November 11 14, 2014 TB Intensive San Antonio, Texas November 11 14, 2014 Extrapulmonary TB Linda Dooley, MD November 13, 2014 Linda Dooley, MD has the following disclosures to make: No conflict of interests No relevant financial

More information

Treatment of Tuberculosis

Treatment of Tuberculosis Treatment of Tuberculosis, 1940 s Treatment of Tuberculosis ATS/CDC/IDSA Joint Statement 2003 Saskatchewan Lung Association Outline, 2012 Treatment of Tuberculosis Principles of treatment of tuberculosis

More information

Contact Investigation

Contact Investigation Tuberculosis Ann Raftery, RN, PHN, MSc GHS Learning Objectives Upon completion of this session, participants will be able to: Describe the criteria used and method for determining the infectious period

More information

Contact Investigation and Prevention in the USA

Contact Investigation and Prevention in the USA Contact Investigation and Prevention in the USA George D. McSherry, MD Division of Infectious Disease Penn State Children s Hospital Pediatric Section TB Center of Excellence Rutgers Global Tuberculosis

More information

TB Program Management San Antonio, Texas November 5-7, 2008

TB Program Management San Antonio, Texas November 5-7, 2008 TB Program Management San Antonio, Texas November 5-7, 2008 Infection Control Lynelle Phillips, RN, MPH November 7, 2008 Infection Control Lynelle Phillips, RN MPH Nurse Consultant Heartland National TB

More information

TB in Children. Rene De Gama Block 10 Lectures 2012

TB in Children. Rene De Gama Block 10 Lectures 2012 TB in Children Rene De Gama Block 10 Lectures 2012 Contents Epidemiology Transmission and pathogenesis Diagnosis of TB TB and HIV Management Epidemiology The year 2000 8.3 million new TB cases diagnosed

More information

Treatment of Tuberculosis Disease. Treatment of Tuberculosis. Decision to Treat Initiation of Therapy 1

Treatment of Tuberculosis Disease. Treatment of Tuberculosis. Decision to Treat Initiation of Therapy 1 Treatment of Tuberculosis Some Highlights of Most Recent Update Treatment of Tuberculosis Disease Germaine Jacquette, MD Physician Specialist NJMS Global Tuberculosis Institute September 15, 2010 The provider

More information

Case Study: TB-HIV co-infection

Case Study: TB-HIV co-infection Case Study: TB-HIV co-infection Julia Greenleaf, RN, MPH Public Health Nurse Public Health Madison & Dane County With guest appearance by Julie Tans-Kersten, MS, BSMT (ASCP) Director, WI TB Program 33

More information

Management of MDR TB. Dr Priscilla Rupali MD; DTM&H Professor and Head Department of Infectious Diseases Christian Medical College Vellore

Management of MDR TB. Dr Priscilla Rupali MD; DTM&H Professor and Head Department of Infectious Diseases Christian Medical College Vellore Management of MDR TB Dr Priscilla Rupali MD; DTM&H Professor and Head Department of Infectious Diseases Christian Medical College Vellore Outline Global epidemiology of Tuberculosis Epidemiology of Tuberculosis

More information

Pediatric TB Theresa Barton, MD

Pediatric TB Theresa Barton, MD TB Nurse Case Management San Antonio, Texas December 8-10, 2009 Pediatric TB Theresa Barton, MD December 9, 2009 Pediatric Tuberculosis Tess Barton, MD Assistant Professor of Pediatrics UT Southwestern

More information

Pulmonary TB aspects

Pulmonary TB aspects Pulmonary TB aspects Nodule & infiltrate Cavern Pneumonia Etienne Leroy Terquem Pierre L Her SPI / ISP Soutien Pneumologique International / International Support for Pulmonology Nodules and infiltrates

More information